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Abstract
Background Transpancreatic biliary sphincterotomy (TPBS) is an advanced cannulation method for accessing common bile 
duct (CBD) in endoscopic retrograde cholangiopancreatography (ERCP). If CBD cannulation is difficult, an endoscopist 
can open the septum between the pancreatic and biliary duct with a sphincterotome to gain access. Long-term results of 
this procedure are unclear. We wanted to evaluate the short- and long-term complications of TPBS on patients with native 
papilla and benign indication for ERCP.
Patients and Methods ERCPs performed in Helsinki University Hospital between 2007 and 2013 were reviewed. The study 
group comprised 143 consecutive patients with TPBS and 140 controls (CG). Data were collected from patient records and 
a phone survey was performed as a follow-up ≥ 4 years after the index ERCP.
Results Post-ERCP pancreatitis (PEP) developed in seven patients (4.9%) in TPBS and one patient (0.7%) in CG (p = 0.067). 
The rates of other acute complications were similar between the groups. ERCP ended with no access to CBD in four cases 
(2.8%) in TPBS. The median length of follow-up was 6 years in TPBS and 7 years in CG. During this period, three patients 
(2.1%) in TPBS and six patients (4.3%) in CG suffered from acute pancreatitis (AP) (p = 0.238). One (0.7%) patient in CG 
and none in TPBS developed chronic pancreatitis (CP). Abdominal pain was suffered by ten patients (6.9%) in TPBS and 
twelve patients (8.6%) in CG daily, whereas by six patients (4.2%) in TPBS and twelve patients (8.6%) in CG weekly.
Conclusion TPBS is a useful procedure, with acceptable complication rates. No significant difference occurred between the 
groups when evaluating the short-term or long-term complications with a follow-up period of four to 10 years. Additionally, 
no significant differences occurred in upper abdominal pain, episodes of AP, or development of CP.
Keywords Transpancreatic biliary sphincterotomy · Endoscopic retrograde cholangiography · Post-endoscopic retrograde 
cholangiopancreatography pancreatitis
ERCP (endoscopic retrograde cholangiopancreatography) 
is one of many methods to examine and treat diseases of 
the bile duct and the pancreatic duct. Cannulation of the 
papilla (papilla Vater) is often performed with a guidewire 
and a sphincterotome. According to the European Society 
of Gastrointestinal Endoscopy (ESGE) guidelines, biliary 
cannulation is defined as difficult if cannulation lasts longer 
than five minutes, success requires more than five attempts, 
or the guidewire accidently passes the pancreatic duct at 
least twice [1]. Therefore, additional cannulation methods 
are often needed in a difficult cannulation [1, 2]. Regardless 
of all methods, final failure occurred in 2.6–18.0% of all 
ERCP procedures [2–4].
One advanced additional cannulation method is transpan-
creatic biliary sphincterotomy (TPBS). TPBS was first 
described by Goff in 1995 [5]. This method involves open-
ing the septum between the common bile duct (CBD) and 
pancreatic duct (PD) if the guidewire unintentionally enters 
the PD. The incision is performed with the sphincterotome 
directed towards the axis of the CBD, in the 11 or 12-o’clock 
direction, to detect the bile duct orifice to cannulate CBD [1, 
5, 6]. The rate of successful CBD cannulation after TPBS is 
85–100% [1]. If TPBS alone is not successful, an additional 
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needle knife (NK) cut can be performed obliquely towards 
10 o`clock from the superior end of the previous TPBS [7].
ERCP is an invasive procedure with an overall complica-
tion rate of approximately 4–11% [8–11]. The most common 
complication is post-ERCP pancreatitis (PEP). Among unse-
lected ERCP patients, the PEP rate was 1.8–4.2% [8–10]. 
In a native papilla cannulation, the PEP rate was 5.3% [2] 
and is rather high 10.8–14.9% in difficult cannulation [1–3, 
11]. When using TPBS as a rescue method in cases of dif-
ficult cannulation, the PEP rate was 7.1–10.4% [2, 7, 12–14]. 
Other possible ERCP complications include cholangitis or 
other infection (1.4%), bleeding (1.3%) and perforation of 
bowel or biliary tract (0.1–0.6%) [9, 15].
PEP was mild or moderate in 90% of the cases. However, 
10% of the PEP patients suffered from a severe form of the 
disease and risk of death among these patients is 3–10% [12, 
16]. The risk of death in all ERCP procedures is 0.06–0.2% 
[9, 11, 17].
Risk factors for PEP can be classified as patient- or 
procedure-related factors. Patient- related factors include a 
patient’s young age, female sex, history of PEP, recurrent 
acute pancreatitis (AP), diseases such as primary scleros-
ing cholangitis (PSC) and sphincter of Oddi dysfunction 
(SOD) [12, 18, 19]. Procedure-related risk factors include 
difficult cannulation, accidental cannulation of PD, long-
lasting ERCP procedures, biliary balloon sphincteroplasty, 
minor papilla sphincterotomy, pancreatic duct injection, 
certain cannulation methods (e.g., TPBS or precut sphinc-
terotomy) and trainee involvement [12, 18, 19]. These risk 
factors increase the risk of PEP synergistically [12]. In addi-
tion, ERCP procedures can be graded according to criteria 
concerning degrees of difficulty [20, 21], which is helpful 
when comparing the risk of complications.
This study aimed to evaluate acute and long-term com-
plications of TPBS. The primary outcomes were develop-
ment of episodes of PEP, AP during the follow-up period, 
development of chronic pancreatitis (CP) and post-sphincter-
otomy stenosis. The secondary outcomes were other ERCP 
complications and re-ERCPs performed during the follow-
up period.
Patients and methods
The study design was a retrospective case–control study 
with a phone survey as a cut point. Calculation of the sam-
ple size involved estimated PEP rates of 2.2% and 10.4% in 
regular wire-guided cannulation and in TPBS, respectively 
(power = 0.8, α = 0.05). According to this calculation, we 
aimed to both include a minimum of 137 participants in both 
groups and have a long-term follow-up period lasting at least 
four years after the first ERCP.
Patients
We reviewed the ERCPs performed between January 2007 
and December 2013 in the Endoscopy Unit of the Helsinki 
University Hospital (HUS). Indications of the needs for 
ERCP were defined from the procedure data. The exclu-
sion criteria identified were primary sclerosing cholangi-
tis (PSC), chronic pancreatitis (CP), biliary or pancreatic 
malignancies, being aged under 18 and deceased patients. 
Remaining in the study after exclusion was 170 consecu-
tive TPBS patients with native papilla. Indications for 
ERCPs in this study were CBD stones, benign biliary 
stricture, problems related to post-liver transplantation 
(stricture), bile leakage after cholecystectomy and SOD. 
For these TPBS patients, we searched for 170 consecu-
tive age- (+ /− 10 years) and sex-matched controls with 
the same inclusion criteria but having successful biliary 
access without requiring TPBS. Of these groups, 143/170 
(84.1%) TPBS patients and 140/170 (82.6%) patients in 
control group (CG) participated in the phone survey and 
comprised the final study groups.
Patients and controls received a letter describing the 
survey and were interviewed by phone within the follow-
ing two weeks. This study was approved by the Committee 
on Ethics of the Helsinki and Uusimaa Hospital District.
Methods
The hospital`s patient data system provided medical 
records and ERCP procedure information.
ERCP procedures were performed with a guidewire and 
a regular sphincterotome (in most of the cases Ultratome®, 
Boston Scientific, Miami, FL). The TPBS was performed 
towards the axis of the CBD, in the 11 or 12-o’clock direc-
tion. The length of the cut was the same as for a regular 
biliary sphincterotomy when removing small (< 1 cm) bil-
iary stones. If needed, additional NK cut was performed 
obliquely towards 10 o’clock, starting from the upper end 
of the previous pancreatic sphincterotomy. The intention 
was to cut the CBD and expose the lumen.
Collected were the following patient demographic data: 
age, sex, BMI (body mass index), ASA (American Society 
of Anesthesiology Physical Status Classification) and lab-
oratory results (bilirubin, plasma amylase before and 4 h 
after ERCP). Additionally collected were ERCP procedure 
data: cannulation method, duration of the ERCP and per-
formed procedures. ERCP procedures were graded by the 
complexity of procedures criteria [20]. If a patient stayed 
overnight at hospital, plasma amylase was assayed 24 h 
after ERCP. Defining PEP occurred when plasma amyl-
ase levels were at least three times the ULN (upper limit 
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of normal) 24 h after ERCP and when new or worsening 
abdominal pain with prolonged hospitalization lasted for 
at least two days [9, 12]. Other complications (bleeding, 
infection, cholangitis and perforation) were classified with 
the same consensus criteria and severity [9]. Late-onset 
AP was defined if a patient suffered from AP between 3 
and 30 days after the ERCP procedure.
A phone survey collected follow-up data: recurrence of 
biliary symptoms (typical upper abdominal pain or diag-
nosed new CBD stones), episodes of AP, abdominal pain 
during the previous year, use of medication (painkillers, pro-
ton pump inhibitors (PPIs), pancreatin), use of alcohol and 
tobacco, symptoms related to pancreatic insufficiency such 
as steatorrhea, development of CP, hospital admissions and 
re-ERCPs or abdominal surgical procedures. Additionally 
collected were the number of re-ERCPs and both indica-
tion of and procedures during ERCP. Biliary stones were 
defined as remnant if new ERCP was required within the 
same hospitalization period and less than one week after a 
previous ERCP; otherwise, the stones were defined as recur-
rent stones.
Statistical methods
Data analysis involved IBM SPSS Statistics for Macintosh, 
Version 25.0. Fisher`s exact test was used for categorical 
variables and Wilcoxon-Mann–Whitney U test for contin-
uous variables when comparing both the two groups and 
interrelations to different variables and PEP. Probability 
below 0.05 was considered statistically significant. Risk fac-
tors for PEP were evaluated with binary logistic regression 
as an odds ratio (OR) and 95% confidential interval (CI).
Results
All the 283 ERCP procedures were therapeutic. Three 
patients in TPBS (one of whom with NK) and two patients 
in CG (one with NK) had undergone previous failed 
ERCP attempts: native papilla was present in 142 and 139 
patients, respectively. ERCP ended with a final failure, that 
is no access to the biliary tract was achieved, in four cases 
(2.8%) in TPBS, whereas all cases in CG were successful, 
as defined in the patient selection, (p = 0.122).
Table 1 presents patient- and ERCP-related characteris-
tics. The majority of the procedures were performed due to 
CBD stones. Other indications were biliary injury after chol-
ecystectomy, biliary pancreatitis, stricture after liver trans-
plantation and suspicion of SOD. Rare indications in TPBS 
included three patients with suspicion of papillary tumor 
or stricture, one patient with non-specific biliary dilatation, 
one with Mirizzi syndrome, one with choledochal cyst and 
one with non-specific icterus. Other rarer indications in CG 
included three patients with non-specified biliary dilatation, 
one patient with suspicion of gallbladder fistula, one with 
recurrent AP and one with suspicion of a liver cyst.
The primary cannulation method in the TPBS group 
was an NK precut in two cases (1.4%) due to a stone in the 
papilla. After precutting, access was possible only to PD, 
thus requiring further TPBS. Cannulation methods in TPBS 
are presented in Fig. 1 and in CG in Fig. 2.
The median duration of ERCP procedure was 27 min 
(7–87  min) in TPBS and 15  min (7–65  min) in CG 
(p < 0.001).
Biliary sphincterotomy (BS) was performed 141 times 
(98.6%) in TPBS and 138 times (98.6%) in CG (p = 1.000). 
One case in the TPBS group had no access to CBD, only 
to PD, and resulted in final failure after bleeding. One case 
was unsuccessful in TPBS + NK, although successful per-
formance of ERCP and BS occurred three days later. In 
CG, one patient had suspected biliary leakage; however, 
due to both normal findings and normal outflow of contrast 
medium, BS was not performed. BS was not performed in 
another case involving a young patient (33 years).
The majority of procedures, that is 125 (87.4%) of TPBS 
and 131 (93.6%) of CG, were classified as difficulty grade 
2 (20).
Table 2 lists the complications related to ERCP pro-
cedures. PEP rates were 4.9% in TPBS and 0.7% in CG 
(p = 0.067, OR for TPBS 7.15, 95% CI for OR 0.869–58.93). 
Complications related to anesthesia or patients’ comorbidi-
ties were pneumonia, acute transient brain ischemic attack 
and worsening of chronic liver dysfunction. One patient in 
both groups suffered from late-onset AP, both of whom were 
classified as mild.
Table 3 presents the PEP rate related to known PEP-risk 
factors and incidence of PEP. According to these factors, no 
significant difference existed between the groups. One male 
and six female patients in the TPBS group suffered from 
PEP. None of the previously known risk factors for PEP 
[12, 18, 19] were significant in this study (data not shown).
CP was diagnosed only in one patient (0.7%) in CG and 
none in TPBS, (p = 0.495). Table 4 presents patient char-
acteristics and phone survey data. The median follow-up 
period was six years in TPBS and seven years in CG.
Three patients (2.1%) in TPBS and six patients (4.3%) 
in CG suffered from AP during the follow-up period 
(p = 0.238). Abdominal pain was a common symptom in 
both groups: 58 patients (40.6%) in TPBS and 50 patients 
(35.7%) in CG mentioned upper abdominal pain in the phone 
survey. Of these patients, ten (6.9%) in TPBS and twelve 
(8.6%) in CG suffered daily from abdominal pain, while six 
patients (4.2%) in TPBS and twelve patients (8.6%) in CG 
suffered weekly. Abdominal pain was categorized as heart-
burn by 32.1% vs. 30.0%, as upper abdominal pain by 32.1% 
vs. 22.0%, as biliary-attack-type pain by 28.3% vs. 22.0% 
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and as other unspecific pain by 7.5% vs. 26.0% in TPBS and 
CG, respectively.
In TPBS, 30 patients (21.1%) and in CG 22 patients 
(15.7%) had taken some medication for abdominal pain 
or symptoms within the previous year. The most common 
medications used were PPIs, metamizole-pitofenone, par-
acetamol and NSAIDs (non-steroidal anti-inflammatory 
drugs).
Table 1  Patient and ERCP 
procedure characteristics
Data are presented as numbers (n) and percentages (%) of patients or as amedian (range)
TPBS transpancreatic biliary sphincterotomy, CG control group, ERCP endoscopic retrograde cholangio-
pancreatography, BMI body mass index, ASA Physical status classification, American society of Anesthesi-
ologists, SOD Sphincter of Oddi dysfunction
Characteristics TPBS n = 143 CG n = 140 p-value
Age at ERCP (years)a 59 (18–93) 62 (21–89) 0.418
Female sex 106 (74.1) 99 (70.7) 0.595
BMI (kg/m2)a 26.0 (16.9–70.3) 27.9 (16.0–47.9) 0.222
ASA grade 0.272
 1 24 (16.8) 22 (15.7)
 2 60 (42.0) 51 (36.4)
 3 49 (34.3) 62 (44.3)
 4 10 (7.0) 5 (3.6)
Final failure 4 (2.8) 0 (0.0) 0.122
Indication for ERCP
 Biliary stone 112 (78.3) 104 (74.3) 0.485
 Biliary stricture 15 (10.5) 11 (7.9) 0.538
 Bile duct injury after cholecystectomy 15 (10.5) 16 (11.4) 0.851
 Biliary pancreatitis 18 (12.6) 24 (17.1) 0.318
 Problems (stricture) after liver transplantation 4 (2.8) 7 (5.0) 0.376
 Other 7 (4.9) 7 (5.0) 1.000
Suspected SOD 6 (4.2) 1 (0.7) 0.120
ERCP as an emergency treatment 36 (25.4) 46 (32.9) 0.236
Periampullary diverticulum 23 (16.1) 15 (10.7) 0.223
Therapy
Biliary sphincterotomy 141 (98.6) 138 (98.6) 1.000
Biliary stone removal 108 (75.5) 104 (74.3) 0.891
TBPS 143 (100.0) 0 (0.0) 0.000
Biliary stent placement 10 (7.0) 13 (9.3) 0.520
Biliary dilatation 6 (4.2) 6 (4.3) 1.000
Pancreatic stent placement (prophylactic) 6 (4.2) 0 (0.0) 0.030
Single operator cholangioscopy 0 (0.0) 1 (0.7) 0.495
ERCP grade of difficulty 0.133
 1 4 (2.8) 4 (2.9)
 2 125 (87.4) 131 (93.6)
 3 14 (9.8) 5 (3.6)
 4 0 (0.0) 0 (0.0)
Pancreatic duct cannulation/wire in pancreatic duct 0.000
 0 0 (0.0) 113 (80.7)
 1 29 (20.3) 17 (12.1)
 2 30 (21.0) 5 (3.6)
 ≥ 3 84 (58.7) 5 (3.6)
Normal plasma bilirubin
pre-ERCP
71/140 (50.7) 71/133 (53.4) 0.717
Hospitalization (nights)a 1 (0–65) 1 (0–16) 0.358
Operator an expert endoscopist 139 (97.2) 130 (92.9)
Operator other/trainee 4 (2.8) 10 (7.1)
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Our evaluation pertained to abdominal pain-related con-
tacts to hospitals after index ERCP. Re-ERCP data are shown 
in Table 5. In all cases, biliary stones were the most common 
indication of re-ERCPs; however, two cases in TPBS and one 
case in CG concerned residual stones. Recurrent stones with 
gallbladder in situ occurred in three cases in both groups. 
Also application, exchange or removal of biliary or pancre-
atic stents were a common re-ERCP indication. The group 
“other” included six ERCPs in CG; one patient underwent 
four different re-ERCPs due to post-pancreatoduodenectomy 
stricture. Two other re-ERCPs were due to icterus (suspicion 
of papillary tumor) in one case and recurrent APs (and later 
diagnosed as CP) in one case.
Performance of re-ERCPs with an acute indication 
(p = 0.505) numbered 16 in TPBS, and 5 in CG. Other re-
ERCPs were scheduled control procedures.
Patients who underwent gastroscopy during the follow-
up period numbered 41 patients (28.7%) in TPBS and 46 
patients (32.9%) in CG (p = 0.445), of whom normal find-
ings occurred in 31 (75.6%) and 30 (65.2%), respectively.
Fig. 1  Data are presented as number (n) of patients and percentages (%). TPBS transpancreatic biliary sphincterotomy, WGC wire-guided can-
nulation, NK needle knife, DGW double guidewire
Fig. 2  Data are presented as number (n) of patients and percentages (%). CG control group, WGC wire-guided cannulation, DGW double guide-
wire, NK needle knife
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Discussion
We aimed to compare short- and long-term complications 
between TPBS and CG with native papilla and similar 
baseline characteristics. The follow-up period was median 
of 6 years in TPBS and 7 years in CG. All 283 patients 
were interviewed by phone, with a high participation rate: 
84.1% in TPBS and 82.6% in CG. Our study provides a 
long follow-up period and is thoroughly performed with a 
matched control group and phone call survey. TPBS had 
acceptable cannulation success rate of 97.2%.
The criteria of difficult CBD cannulation by the Scandina-
vian Association for Digestive Endoscopy (SADE) research 
group and later by ESGE was published in 2014 and 2016 
[1, 2]. The patients in our study underwent ERCPs between 
2007 and 2013, when the criteria for difficult cannulation 
were unclear. However, patients in this study needing TPBS 
for successful CBD cannulation fulfilled the requirements of 
difficult cannulation in a retrospective evaluation. Fulfilling 
the requirements mostly related to PD passages, as seen in 
Table 1. In addition to guidewire passages to PD, the median 
length of the procedure was significantly longer in TPBS 
group, (27 min), twice as long as in CG group (15 min), 
indicating the difficult cannulation situation. There were no 
differences in performed procedures after cannulation, thus 
the longer procedure time was related to more time spent to 
cannulate. It is impossible, however, to determine the exact 
cannulation times and attempts retrospectively.
Only few studies have evaluated the long-term complication 
risks of TPBS [22, 23] or pancreatic sphincterotomy (PS) when 
PS was performed to gain the access to PD [24, 25]. As stated 
in a recent meta-analysis, long-term follow-up studies in TPBS 
are lacking [13]. In these studies, the median follow-up period 
ranged from four to five months in TPBS and 41 months in 
PS. Results mainly concentrate on AP or other acute compli-
cations [5, 22–26]. However, these studies have several limi-
tations. Miao et al. followed 36 patients with TPBS for four 
months [22]. During that period, patients had no recurrent bil-
iary stones or symptoms related to SOD. Kahaleh et al. evalu-
ated 116 TPBS patients in a prospective study with a follow-up 
median of five months but results concentrated on short-term 
complications [23]. In a retrospective study, Park el al. included 
only SOD patients with both BS and PS with median follow-up 
of 41 months, the long-term outcome being a need for reinter-
vention [25]. Kozarek et al. included only patients with CP and 
PS, 14% of whom required repeated endoscopic or surgical 
sphincter section [24]. These studies are not fully comparable 
to ours due to the shorter follow-up period and different patient 
group. Patients undergoing ERCP with symptoms related to 
SOD or CP are a different group than our patients who under-
went ERCP for benign indications and targeting to CBD. PEP 
rate in this meta-analysis was 8.1% in prospective studies [13], 
and it is comparable to our PEP rate of 4.9%.
We have performed TPBS in difficult cannulation situation 
for several years and collected the data to provide a large patient 
series to confront the long-term complication issue. We wanted 
to explore if patients with TPBS have more CP or symptoms 
related to papillary stenosis, for example AP episodes. There-
fore, we needed the follow-up period to last for several years. 
However, we found no relations between TPBS and CP or pap-
illary stenosis. Concerns with TPBS included increased risk of 
complications, additionally long-term consequences of PS in 
cases when the target is not PD, and a risk of papillary stenosis 
that may lead to recurrent pancreatitis [27–29].
Table 2  Complications of ERCP procedures
Data are presented as numbers (n) and percentages (%) of patients
ERCP endoscopic retrograde cholangiopancreatography, TPBS 
transpancreatic biliary sphincterotomy, CG control group, PEP post-
ERCP pancreatitis (classification according to Cotton et al. [9])
Complications TPBS n = 143 CG n  = 140 p-value
PEP 7 (4.9) 1 (0.7) 0.067
 Mild 2 (1.4) 1 (0.7)
 Moderate 3 (2.1) 0 (0.0)
 Severe 2 (1.4) 0 (0.0)
Cholangitis 1 (0.7) 1 (0.7) 1.000
Perforation 3 (2.1) 1 (0.7) 0.622
 (a) Biliary tract 2 (1.4) 1 (0.7)
 (b) Bowel 1 (0.7) 0 (0.0)
Bleeding 2 (1.4) 2 (1.4) 1.000
Other 3 (2.1) 0 (0.0) 0.247
Table 3  Incidence of post-ERCP pancreatitis according to risk factors
Data are presented as numbers (n) of post-ERCP pancreatitis patients 
with risk factor in number (N) of patients with particular risk factor 
and percentages (%)
ERCP endoscopic retrograde cholangiopancreatography, TPBS 
transpancreatic biliary sphincterotomy, CG control group, AP acute 
pancreatitis, NK needle knife, SOD sphincter of Oddi dyskinesia
Risk factors TPBS n = 7 CG n = 1 p-value
Female sex 6/106 (5.7) 1/99 (1.0) 0.452
Age < 40 years 2/24 (8.3) 0/22 (0.0) 0.620
Female < 40 years 2/18 (11.1) 0/13 (0.0) 0.449
History of AP 0/7 (0.0) 0/1 (0.0) 1.000
Normal serum bilirubin 4/67 (6.0) 0/62 (0.0) 1.000
ERCP duration > 40 min 3/32 (9.4) 0/7 (0.0) 0.097
Pancreatic duct opacification 0/8 (0.0) 0/0 (0.0) 1.000
NK precut 0/7 (0.0) 0/1 (0.0) 1.000
Sphincterotome precut 0/7 (0.0) 0/1 (0.0) 1.000
Suspected SOD 1/6 (16.7) 0/1 (0.0) 0.184
Biliary stone extraction 6/108 (5.6) 1/104 (1.0) 0.684
Biliary sphincterotomy 7/141 (5.0) 1/138 (0.7) 1.000
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Table 4  Patient characteristics 
at phone survey and follow-up 
data
Data are presented as numbers (n) and percentages (%) of patients or as amedian (range)
TPBS transpancreatic biliary sphincterotomy, CG control group, AP acute pancreatitis, CP chronic pan-
creatitis
Characteristics TPBS n = 143 CG n = 140 p-value
Age at phone survey (years)a 66 (25–101) 69 (28–96) 0.253
Follow-up period (years)a 6 (4–10) 7 (4–10) 0.016
Cigarette smoking 14 (9.8) 11 (7.9) 0.677
Cigarettesa/day 15 (6–30) 10 (1–20) 0.061
Alcohol consumption 62 (43.7) 64 (46.0) 0.720
Comorbidities 117 (81.8) 112 (80.0) 0.763
Cardiovascular disease 77 (53.8) 78 (55.7) 0.811
Diabetes 21 (14.7) 25 (17.9) 0.521
Chronic lung disease 24 (16.8) 15 (10.7) 0.168
Musculoskeletal disease 44 (30.8) 44 (31.4) 1.000
Cerebrovascular disease 13 (9.1) 12 (8.6) 1.000
Gastrointestinal diseases 34 (23.8) 25 (17.9) 0.244
Endocrine diseases 10 (7.0) 27 (19.3) 0.003
Urinary tract/kidney diseases 11 (7.7) 7 (5.0) 0.466
Neurological/psychiatric disease 11 (7.7) 8 (5.7) 0.636
Other chronic disease 7 (4.9) 7 (5.0) 1.000
Cholecystectomy 118 (82.5) 117 (83.6)
AP episodes during the follow-up period 0.238
 0 140 (97.9) 134 (95.7)
 1 2 (1.4) 5 (3.6)
 2 1 (0.7) 0 (0.0)
 ≥ 3 0 (0.0) 1 (0.7)
Development of CP 0 (0.0) 1 (0.7) 0.495
Table 5  Re-ERCPs during the 
follow-up period
Data are presented as numbers (n) and percentages (%) of patients
TPBS transpancreatic biliary sphincterotomy, CG control group, ERCP endoscopic retrograde cholangio-
pancreatography
TPBS CG p-value
Number of patients n (%) 18 (12.6) 7 (5.0) 0.035
Number of re-ERCPs 29 13 0.018
None 125 (87.4) 133 (95.0)
Once 11 (7.7) 5 (3.6)
Twice 3 (2.1) 0 (0.0)
Three times 4 (2.8) 1 (0.7)
Five times 0 (0.0) 1 (0.7)
Indications for re-ERCPs n = 29 n = 13 0.002
Biliary stones 10/29 (34.5) 4/13 (30.8)
Biliary stricture, stent exchange /apply /removal 8/29 (27.6) 1/13 (7.7)
Previous ERCP complication (bleeding or perforation) 4/29 (13.8) 0 (0.0)
Pancreatic stent exchange/apply/removal 4/29 (13.8) 2/13 (15.4)
Biliary injury after cholecystectomy 3/29 (10.3) 0 (0.0)
Other 0/29 (0.0) 6/13 (46.2)
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Late complications like papillary stenosis and ductal stric-
tures are only encountered at least 3 months after the proce-
dure indicating a need for long term follow-up [30].
In difficult cannulation, if advanced cannulation meth-
ods, such as TPBS, are needed, the risk of PEP arises [1, 2]. 
By the ESGE [1], TPBS should be considered as a rescue 
method in difficult cannulation but performed by experienced 
endoscopists due to its higher complication rates. Training 
of the TPBS technique should be focused only for trainees 
already being able to practice standard ERCP independently. 
Testoni et al., in their algorithm of biliary cannulation, placed 
TPBS as a third or a fourth cannulation method after DGW 
and/or NK precut techniques [31]. Similarly in ESGE guide-
lines, TPBS is recommended in difficult cannulation cases 
after failed attempts with standard or DGW cannulation. Sug-
iyama et al. performed a randomized study and suggested that 
TPBS should be considered as a rescue method and performed 
earlier in difficult cannulation [32]. As shown with our data, 
TPBS is safe also on a long-term scale. Therefore, we also 
suggest earlier performance of TPBS in difficult cannulation.
In HUS, prophylactic pancreatic stents were seldom used 
during the study period. The ESGE has suggested that place-
ment of prophylactic stents might reduce the PEP rate [1, 12]. 
Six patients (4.2%) in TPBS had prophylactic pancreatic stent 
in our study (Table 1). Still, in this study, a PEP rate of 4.9% in 
the whole TPBS group is acceptable. At the moment, there are 
no clear data that after proper PS prophylactic pancreatic stent 
is beneficial (12) but randomized trials are needed.
Our follow-up study found no patients with stricture or CP 
in TPBS group. Notable, however, are limitations regarding 
patient selection and retrospective manner. Patients in both 
groups suffered from upper abdominal pain. However, no dif-
ferences existed in the frequency or severity of the pain. Most 
of the patients had symptoms related to recurrent biliary stones 
or heartburn. Painkillers or PPIs were equally used in both 
groups. The most common reason for evaluating the follow-up 
contacts to healthcare were upper abdominal pain and symp-
toms related to biliary stones. Due to these symptoms, the most 
common procedures were cholecystectomy and gastroscopy.
According to a previous study in HUS, the TPBS method 
has been successful and is therefore commonly used as a res-
cue method in our unit [7]. We suggest further prospective 
studies to evaluate the long-term risks of TPBS.
Limitations of the study
Possible bias in this study relates to the patient selection pro-
cess. We wanted to interview all the patients; therefore, the 
inclusion criteria considered only benign indications for ERCP. 
PEP rates are slightly lower in the present study than in previ-
ous studies in the HUS endoscopy unit in ERCP patients with 
TPBS [7, 33]. Nevertheless, malignancy is not considered a 
risk factor for PEP. The ESGE guidelines for indomethacin or 
diclofenac as a PEP prophylaxis [12] was adopted in our unit 
in November 2013. In this study, only four patients underwent 
ERCP after November 2013 and only one patient in TPBS 
group received prophylactic rectal diclofenac. The ESGE defi-
nition for difficult cannulation was published in year 2016 [1]. 
Our study included patients between years 2007 and 2013, 
and we started to collect the data (cannulation duration and 
attempts) in March 2011. However, the missing data should 
not affect at least the long-term complications of TPBS.
Conclusions
TPBS is a useful rescue method in difficult cannulation, hav-
ing an acceptable complication rate. No significant differ-
ence occurred between groups when evaluating the short- or 
long-term complications. Additionally, no significant dif-
ferences occurred during the follow-up period concerning 
upper abdominal pain, usage of painkillers, episodes of AP 
or development of CP.
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